Egypt's pharmaceutical imports stood at 43 million USD in 2023. Forecast data indicates a consistent year-on-year increase in the import value of pharmaceutical goods from 2024 to 2028. In 2024, the value is expected to be 45.934 million USD, representing a 6.83% increase from the previous year. The import value continues to rise, reaching 47.035 million USD in 2025, 48.114 million USD in 2026, 49.172 million USD in 2027, and 50.208 million USD in 2028. This consistent growth results in a Compound Annual Growth Rate (CAGR) of around 3.35% over the five-year forecast period.
The key trends to watch for in the future include:
- Changes in government policy and regulations affecting pharmaceutical imports.
- Impact of technological advancements on the local pharmaceutical manufacturing capabilities.
- Influence of global economic conditions on pharmaceutical import prices and demand.
- Evolving healthcare needs and demographic shifts within Egypt that could affect pharmaceutical consumption patterns.
- Potential partnerships and investments in the local pharmaceutical sector by international companies.
